Apeloa Pharmaceutical Co. Ltd. A | Ownership
Companies that own Apeloa Pharmaceutical Co. Ltd. A
Zhong Ou Asset Management Co., Ltd
21,024,209
1.83%
9,723,871
0.4%
03/31/2018
GF Fund Management Co., Ltd.
10,028,800
0.87%
-2,849,900
0.13%
12/31/2017
Guotai Asset Management Co., Ltd.
7,500,000
0.65%
-5,388,109
0.12%
12/31/2017
HuaAn Fund Management Co., Ltd.
5,471,100
0.48%
-17,504,959
0.08%
12/31/2017
The Vanguard Group, Inc.
1,977,321
0.17%
-382,529
0%
07/31/2018
Western Leadbank Fund Management Co., Ltd
843,440
0.07%
310,000
0.05%
12/31/2017
Acadian Asset Management LLC
409,100
0.04%
0
0%
07/31/2018
Fuanda Fund Management Co., Ltd.
330,000
0.03%
330,000
0.1%
12/31/2017
Changsheng Fund Management Co., Ltd.
51,700
0.01%
-776,543
0%
12/31/2017
China Southern Asset Management Co., Ltd.
16,500
0%
-800
0%
12/31/2017
| Address |
No. 333 Hengdianjiang South Road
Dongyang Zhejiang 322118
China
|
|
Employees
|
- |
| Website |
http://www.apeloa.com |
| Updated |
07/08/2019 |
| Apeloa Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredients, and drug preparation. Its products include levofloxacin hydrochloride, amantadine hydrochloride, ofloxacin, adamantane, and other pharmaceutical ingredients. It also offers capsules, ointment, granules, and injections. |
